Can Fite Biofarma Ltd.

13F holders, Q1 2025 (March 31)
14holders +1
5new positions
4sold out
$1.48avg. 13F price*

At the end of Q1 2025, 14 institutions reported holding Can Fite Biofarma Ltd. in their 13F filings, up 1 from Q4 2024. 5 opened new positions and 4 sold out. The largest holders were Rhumbline Advisers ($57K), Morgan Stanley ($34K) and BNP Paribas Financial Markets ($33K).

Company
Can Fite Biofarma Ltd.
CUSIP
13471N300
Latest filing quarter
Q4 2025

History

Number of 13F holders

05101520 Q1 2024: 8Q1 2024Q2 2024: 11Q2 2024Q3 2024: 12Q3 2024Q4 2024: 13Q4 2024Q1 2025: 14Q1 2025Q2 2025: 16Q2 2025Q3 2025: 16Q3 2025Q4 2025: 15Q4 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions5$60K
Exits4$38K

All 13F filers, Q4 2024 → Q1 2025: 52,333 shares bought and 35,429 shares sold, net +16,904 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 14 holders

Rhumbline Advisers 0.00% Add +42.4% 38,268 $57K
Morgan Stanley 0.00% Reduce -28.6% 23,212 $34K
BNP Paribas Financial Markets 0.00% Reduce -10.3% 22,585 $33K
XTX Topco Ltd 0.00% New 15,271 $23K
Virtu Financial LLC 0.00% New 13,740 $20K
Captrust Financial Advisors 0.00% New 10,634 $16K
Fifth Third Bancorp 0.00% No change 3,000 $4K
Wells Fargo & Company 0.00% Add +8.0% 2,700 $4K
Costello Asset Management, INC 0.00% New 1,000 $1K
National Bank of Canada 0.00% No change 600 $888
Activest Wealth Management 0.00% No change 200 $296
TD Waterhouse Canada Inc. 0.00% No change 20 $28
SBI Securities Co., Ltd. 0.00% No change 1 $1
Avion Wealth 0.00% New 100 $0

"% of holder's portfolio" is CAN FITE BIOFARMA LTD's weight in each manager's 13F, not the share of Can Fite Biofarma Ltd. the manager owns.